Insider · CIK 0001201256
Michael S Wyzga
Files at TVRD (Tvardi Therapeutics, Inc.), XFOR (X4 Pharmaceuticals, Inc), MREO (Mereo BioPharma Group plc). First filing -, latest -.
Michael S Wyzga files SEC Form 4 as director at TVRD (Tvardi Therapeutics, Inc.), and also at XFOR (X4 Pharmaceuticals, Inc), MREO (Mereo BioPharma Group plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael S Wyzga has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | AGrant or award Share Options (Right to buy)derivative | +66,000 | $0.00 | $0 | 66,000 | Feb 27, 2026 |
| Jan 1, 2026 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +110,000 | $0.00 | $0 | 0 | Jan 5, 2026 |
| Jun 9, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Common Stock | +1,500 | $0.00 | $0 | 5,555 | Jun 10, 2025 |
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,000 | $0.00 | $0 | 12,000 | Apr 21, 2025 |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +18,441 | - | - | 18,441 | Apr 17, 2025 |
Questions about Michael S Wyzga
Answered from the filings on this page, as of the latest one.
Is Michael S Wyzga buying or selling?
Michael S Wyzga has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael S Wyzga's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael S Wyzga has 0.
Where does Michael S Wyzga file Form 4?
Michael S Wyzga has filed Form 4 at TVRD (Tvardi Therapeutics, Inc.); XFOR (X4 Pharmaceuticals, Inc); MREO (Mereo BioPharma Group plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.